Apollon Wealth Management, LLC Novartis Ag Transaction History

Apollon Wealth Management, LLC

$5.29 Billion
Q3 2025

A detailed history of Apollon Wealth Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 10,791 shares of NVS stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,791

Previous 10,855 0.59%

Holding current value

$1.34 Million

Previous $1.31 Million 5.33%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 16, 2025	SELL	$113.5 - $129.73 $7,264 - $8,302	-64 Reduced 0.59%	10,791 $1.38 Million
Q2 2025 Jul 24, 2025	BUY	$101.96 - $121.01 $10,603 - $12,585	104 Added 0.97%	10,855 $1.31 Million
Q1 2025 May 01, 2025	SELL	$97.14 - $115.57 $106,271 - $126,433	-1,094 Reduced 9.24%	10,751 $1.2 Million
Q4 2024 Jan 28, 2025	BUY	$96.78 - $117.18 $89,618 - $108,508	926 Added 8.48%	11,845 $1.15 Million
Q3 2024 Nov 04, 2024	SELL	$106.13 - $120.89 $52,428 - $59,719	-494 Reduced 4.33%	10,919 $1.26 Million
Q2 2024 Jul 19, 2024	SELL	$92.57 - $107.37 $146,445 - $169,859	-1,582 Reduced 12.17%	11,413 $1.22 Million
Q1 2024 May 02, 2024	SELL	$95.27 - $108.47 $5,239 - $5,965	-55 Reduced 0.42%	12,995 $1.26 Million
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $737,237 - $811,304	7,990 Added 157.91%	13,050 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $25,861 - $28,700	273 Added 5.7%	5,060 $515,000
Q2 2023 Aug 04, 2023	BUY	$92.52 - $104.91 $75,773 - $85,921	819 Added 20.64%	4,787 $483,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $9,443 - $10,951	-118 Reduced 2.89%	3,968 $365,000
Q4 2022 Feb 15, 2023	SELL	$75.55 - $92.52 $113,022 - $138,409	-1,496 Reduced 26.8%	4,086 $370,000
Q3 2022 Nov 08, 2022	BUY	$74.61 - $87.26 $122,211 - $142,931	1,638 Added 41.53%	5,582 $424,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $101,294 - $117,937	-1,258 Reduced 24.18%	3,944 $333,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $410,723 - $464,608	-5,127 Reduced 49.64%	5,202 $456,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $479,236 - $529,925	6,013 Added 139.32%	10,329 $904,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $352,962 - $410,624	4,316 New	4,316 $353,000
Q3 2020 Nov 03, 2020	SELL	$82.14 - $91.0 $903 - $1,001	-11 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $890 - $1,002	11 New	11 $1,000

Others Institutions Holding NVS

# of Institutions

1,582

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $266B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Account

Apollon Wealth Management, LLC Novartis Ag Transaction History